Literature DB >> 7545550

Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages.

Y Hattori1, N Nakanishi.   

Abstract

We evaluated the effects of the immunosuppressants cyclosporin A (CsA) and FK506 on the synthesis of nitric oxide (NO) induced by bacterial lipopolysaccharide (LPS) in J774 macrophages. CsA and FK506 each inhibited NO production by LPS in a concentration-dependent fashion, but the cytotoxicity was also evident at higher concentrations (100 microM). Neither CsA nor FK506 had any effect on the activity of NO synthase (NOS) that had already been induced. Findings indicated that CsA and FK506 inhibit the induction of NOS, rather than its catalytic activity. CsA and, to a lesser extent, FK506 increased the synthesis of tetrahydrobiopterin (BH4), an essential cofactor of NOS. Thus, inhibition of NO formation by CsA or FK506 is unlikely to associated with a change in BH4 synthesis caused by these agents in LPS-treated J774 macrophages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545550     DOI: 10.1006/cimm.1995.1180

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  Protective effects of cyclosporin-A in splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; M Ferlito; B Deodato; M Arlotta; L Minutoli; G M Campo; A Bova; C Quartarone; G Urna; A Sardella; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages.

Authors:  S Hortelano; E López-Collazo; L Boscá
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.

Authors:  C E Soma; C Dubernet; G Barratt; F Nemati; M Appel; S Benita; P Couvreur
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

4.  Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; M Ferlito; G M Campo; M Arlotta; S Grimaldi; C Quartarone; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid.

Authors:  Riku Korhonen; Riitta Korpela; Eeva Moilanen
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

6.  The calcineurin inhibitor cyclosporine A improves lipopolysaccharide-induced vascular dysfunction but does not rescue from cardiovascular collapse in endotoxemic mice.

Authors:  Mette Stæhr; Apameh Khatam-Lashgari; Paul M Vanhoutte; Pernille B L Hansen; Boye L Jensen
Journal:  Pflugers Arch       Date:  2013-05-21       Impact factor: 3.657

7.  New 1-aryl-3-substituted propanol derivatives as antimalarial agents.

Authors:  Silvia Pérez-Silanes; Luis Berrade; Rory N García-Sánchez; Adela Mendoza; Silvia Galiano; Berta Martín Pérez-Solórzano; Juan J Nogal-Ruiz; Antonio R Martínez-Fernández; Ignacio Aldana; Antonio Monge
Journal:  Molecules       Date:  2009-10-14       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.